A randomised trial of electro-acupuncture for arthralgia related to aromatase inhibitor use
详细信息    查看全文
文摘

Background

Arthralgia is a common and debilitating side-effect experienced by breast cancer patients receiving aromatase inhibitors (AIs) and often results in premature drug discontinuation.

Methods

We conducted a randomised controlled trial of electro-acupuncture (EA) as compared to waitlist control (WLC) and sham acupuncture (SA) in postmenopausal women with breast cancer who self-reported arthralgia attributable to AIs. Acupuncturists performed 10 EA/SA treatments over 8 weeks using a manualised protocol with 2 Hz electro-stimulation delivered by a TENS unit. Acupuncturists administered SA using Streitberger (non-penetrating) needles at non-traditional acupuncture points without electro-stimulation. The primary end-point was pain severity by Brief Pain Inventory (BPI) between EA and WLC at Week 8; durability of response at Week 12 and comparison of EA to SA were secondary aims.

Findings

Of the 67 randomly assigned patients, mean reduction in pain severity was greater in the EA group than in the WLC group at Week 8 (鈭?.2 versus 鈭?.2, p = 0.0004) and at Week 12 (鈭?.4 versus 鈭?.2, p < 0.0001). Pain-related interference measured by BPI also improved in the EA group compared to the WLC group at both Week 8 (鈭?.0 versus 0.2, p = 0.0006) and Week 12 (鈭?.1 versus 鈭?.1, p = 0.0034). SA produced a magnitude of change in pain severity and pain-related interference at Week 8 (鈭?.3, 鈭?.5 respectively) and Week 12 (鈭?.7, 鈭?.3 respectively) similar to that of EA. Participants in both EA and SA groups reported few minor adverse events.

Interpretations

Compared to usual care, EA produced clinically important and durable improvement in arthralgia related to AIs in breast cancer patients, and SA had a similar effect. Both EA and SA were safe.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700